Diseases Market Research Reports

Medical Diseases Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
Common Disease Treatment Drugs Markets in China (13 Full Research Reports Collection)

Common Disease Treatment Drugs Markets in China (13 Full Research Reports Collection)

Date Published: Jan 15 2014

China's demand for common disease treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 13 full market research reports:

$12,000.00
PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

Summary

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

Highlights

Key Questions Answered

$10,995.00
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

Date Published: Nov 30 2013

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023

Date Published: Mar 31 2014
$10,995.00
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2022

Date Published: Feb 28 2014

PharmaPoint: Schizophrenia Global Drug Forecast and Market Analysis to 2022

 

Summary

$10,995.00
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Dec 31 2013

PharmaPoint: Epilepsy Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

 

Summary

$10,995.00
PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

Summary

There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective, these therapies are still lacking because of their immunosuppressant nature and lack of understanding as to their exact mechanism of action.

Highlights

Key Questions Answered

$10,995.00
PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

Date Published: Mar 31 2014
$10,995.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2014
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines Global Drug Forecast and Market Analysis to 2022
Prophylactic Hepatitis B Virus Vaccines Global sales to reach over $1.1 billion by 2022.
$10,995.00
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Apr 30 2014

PharmaPoint: Non-Small Cell Lung Cancer Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

 

Summary

$10,995.00
PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022

Date Published: Apr 30 2014

PharmaPoint: Neuropathic Pain Global Drug Forecast and Market Analysis to 2022

 

Summary

$10,995.00
PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022

Date Published: Jun 30 2013

PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

Date Published: Mar 31 2014
$10,995.00
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Jan 31 2014
$10,995.00
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: May 31 2014

PharmaPoint: Hepatitis C Virus Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

 

Summary

$10,995.00
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

Date Published: Jan 31 2013

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

Summary

$10,995.00
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

Date Published: Jun 30 2013

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

Date Published: Feb 28 2014
PharmaPoint: Ulcerative Colitis Global Drug Forecast and Market Analysis to 2022
Global ulcerative colitis (UC) market is expected to reached $6.6 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 4.7%.
 

Summary

$10,995.00
PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2014
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as - 
  • Takeda’s alpha4beta7 inhibitor, Entyvio (vedolizumab)
  • Johnson & Johnson’s (J&J’s) interleukin (IL)-12/23 inhibitor, Stelara (ustekinumab)
 
$10,995.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data